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Abstract
Yeast Ufd2p was the first identified E4 multiubiquitin chain assembly factor. Its vertebrate homologues later referred to as
UFD2a, UBE4B or E4B were also shown to have E3 ubiquitin ligase activity. UFD2a function in the brain has been well
established in vivo, and in vitro studies have shown that its activity is essential for proper condensation and segregation of
chromosomes during mitosis. Here we show that 2 alternative splice forms of UFD2a, UFD2a-7 and -7/7a, are expressed
sequentially during myoblast differentiation of C2C12 cell cultures and during cardiotoxin-induced regeneration of skeletal
muscle in mice. UFD2a-7 contains an alternate exon 7, and UFD2a-7/7a, the larger of the 2 isoforms, contains an additional
novel exon 7a. Analysis of protein or mRNA expression in mice and zebrafish revealed that a similar pattern of isoform
switching occurs during developmental myogenesis of cardiac and skeletal muscle. In vertebrates (humans, rodents,
zebrafish), UFD2a-7/7a is expressed only in mature striated muscle. This unique tissue specificity is further validated by the
conserved presence of 2 muscle-specific splicing regulatory motifs located in the 39 introns of exons 7 and 7a. UFD2a
interacts with VCP/p97, an AAA-type ATPase implicated in processes whose functions appear to be regulated, in part,
through their interaction with one or more of 15 previously identified cofactors. UFD2a-7/7a did not interact with VCP/p97
in yeast 2-hybrid experiments, which may allow the ATPase to bind cofactors that facilitate its muscle-specific functions. We
conclude that the regulated expression of these UFD2a isoforms most likely imparts divergent functions that are important
for myogenisis.
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Introduction
The way in which cells achieve their differentiation program is
intimately tied to changes in their proteome occurring via several
mechanisms including, post-translational modification, de novo
transcription, ubiquitin dependant proteasomal degradation, and
specific regulation of tissue-specific splicing factors resulting in
alternatively spliced transcripts. Several recent genome wide
screens have estimated that over 90% of all genes are alternatively
spliced and that more than 50% of all alternative splicing events
differ by tissue type, with muscle displaying the 3
rd highest number
of alternatively spliced transcripts [1,2,3]. Between 60 and 95
distinct splicing transitions have been detected during cardiac
development and skeletal muscle differentiation more than half of
which are conserved between mammalian and avian species [4,5].
Troponins, titin, MEF-2, and MBNL proteins represent specific
examples of developmentally regulated splicing events which affect
protein function, localization and/ or binding specificity in these
tissues [6,7,8,9].
Proteasome-dependant protein turnover is also critical for the
dramatic alterations in the proteome that occur during myogen-
esis. The temporal regulation of muscle-specific transcriptional
events is regulated by the dependant degradation of myogenic
transcription factors such as MyoD and Myf5 and their regulatory
cofactors [10,11,12,13]. In addition, multiple structural compo-
nents of the sarcomere are substrates of the ubiquitin proteasome
system (UPS) [14,15]. During development, ubiquitin-dependant
degradation facilitates myosin heavy chain (MHC) isoform
switching [16] and the is crucial for turnover of myosin binding
chaperones that affect overall sarcomere assembly [17,18,19,20].
The UPS is a multi-enzyme, ATP-dependent process which
generally requires three enzymes: an E1 ubiquitin activating
enzyme, an E2 ubiquitin conjugating enzyme, and an E3 ubiquitin
protein ligase. These enzymes catalyze the covalent attachment of
the ubiquitin polypeptide to a target protein, followed by the
attachment of further ubiquitin peptides onto already attached
ubiquitin. The majority of the target protein specificity is mediated
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examples have been described from three main gene families
[21,22]. In some cases, multi-ubiquitination requires the addition-
al activity of an E4 ligase, which binds to proteins with just a few
ubiquitin molecules and catalyses multiubiquitin-chain assembly in
collaboration with E3 ligases. Polyubiquitinated proteins are then
targeted for proteolytic destruction by the proteasome.
UFD2a (also referred to as E4B/Ube4b) is an E3/4 ubiquitin
ligase that we and others have recently characterized in vertebrates
[23,24,25]. The carboxy terminus of UFD2a contains a U-box
which is related to the more common RING domain [26] and was
shown to contain the active site for UFD2a ubiquitin ligase activity
as well as the binding site for the two E2 enzymes with which it
associates, UbcH5c and Ubc4 [24,25,27,28,29,30]. We later
determined that a novel amino terminal domain, the MPAC
(Mitotically Phosphorylated, Apoptotically Cleaved), not present in
lower eukaryote UFD2a orthologs, was also required for full E3
ligase activity [28].
In human cells, RNAi knockdown of UFD2a led to aberrant
chromosomal condensation and segregation, mitotic arrest and
apoptosis, demonstrating that UFD2a was essential for proper
progression through mitosis. Examination of UFD2a function in
vivo has mainly focused on its role in the central nervous system
(CNS). Specifically, UFD2a is implicated in spinocerebellar ataxia
type-3 (SCA) [27] and UFD2a ubiquitination activity is required
for normal CNS development [31]. Overexpression of UFD2a in
transgenic mice resulted in accumulation of ubiquitin containing
aggregates in hypothalamic neurons, which led to significant
metabolic abnormalities and obesity [32]. The only evidence for
UFD2a function in other tissues in vivo, was shown in mice
homozygous for the U-box deletion which died in utero of massive
cardiomyocyte apoptosis [31]. However, the mechanism of
UFD2a involvement in muscle tissue development or function
has not been characterized.
Here we identify two cardiac and skeletal muscle-specific
isoforms of UFD2a, UFD2a-7 and UFD2a-7/7a. We show that
these isoforms arise from alternative splicing of the UFD2a pre-
mRNA and include one and two additional exons, respectively,
compared to the ubiquitously expressed isoform of UFD2a. The
expression and tissue specificity of these alternative transcripts, as
well as the presence of several muscle specific intronic regulatory
motifs in intron 7 appear to be conserved among several vertebrate
species including human, mouse, rat and zebrafish. Interestingly,
while UFD2a-7/7a is expressed in mature and regenerating
muscle, UFD2a-7 is expressed only transiently during muscle
regeneration in vivo. We find that this pattern of isoform switching
also occurs during embryonic development in mice. Finally, the
mature muscle specific isoform, UFD2a-7/7a, fails to bind to the
multi-functional AAA type ATPase, VCP/p97, an interaction that
has been well documented for UFD2a across species.
Results
A novel form of UFD2a is expressed in skeletal muscle
and cardiac muscle
Previous studies by our group and others have shown that
UFD2a is widely expressed in multiple cell types and tissues in
vertebrates [24,25]. However, Western blot analysis revealed that
UFD2a expressed in skeletal muscle migrated significantly slower
on SDS-PAGE than in other tissues, suggesting a muscle tissue–
specific alternate isoform (Fig. 1A). Western blot analysis of other
muscle tissues revealed that the larger isoform is also expressed in
human cardiac tissue (Fig. 1B). Coronary arteries, which are an
abundant source of smooth muscle, were analyzed from the same
donors, but only the ubiquitous form of UFD2a was expressed in
that tissue. Small intestine, another prominent source of smooth
muscle, also expressed only the ubiquitous form (not shown),
suggesting that the larger isoform of UFD2a is specifically
expressed in striated muscle. We have previously shown that
UFD2a is highly phosphorylated in mitotic cells, which increases
its molecular size [23,28]. However, the muscle-specific isoform
did not comigrate with phosphorylated UFD2a from cells arrested
in G2/M with nocodazole (upper band of doublet seen in lane 9
Fig. 1A), and unlike the mitotic phosphorylated forms of UFD2a
[23,28], the muscle-specific form was insensitive to treatment with
l protein phosphatase (Fig 1C, long exposure).
The muscle-specific form of UFD2a includes 2 isoforms
with alternatively spliced exons
RT-PCR of muscle and nonmuscle cDNA revealed the
presence of skeletal muscle-specific expanded Ufd2a cDNA
sequence. Multiple primer pairs were used to amplify different
portions of the UFD2a cDNA. A primer pair specific for sequences
near the 59-end of the UFD2a gene amplified an expected 830-bp
fragment of cDNA derived from human primary macrophages
and transformed erythroblast cells. However, a dominant 1370-bp
fragment, and one 1217-bp intermediate, in addition to trace
amounts of the expected 830-bp fragment were detected in human
muscle cDNA (Fig. 1D and data not shown). RT-PCR using
primers that recognize a sequence nearer the 39-end of the UFD2a
gene, as well as those recognizing the housekeeping gene HPRT,
amplified the same-sized product from all sources examined.
Muscle and nonmuscle RT-PCR products were analyzed by
sequence analysis. Nonmuscle amplicons matched exactly the
UFD2a RefSeq entry (Accession NM_006048) in the NCBI
sequence database. The dominant 1370 bp muscle amplicons
(largest band in Fig. 1D) contained the same sequence with an
additional 540 bp of novel sequence. The novel sequence was
inserted after amino acid 270 within the N-terminal region not
present in lower eukaryotes such as yeast and drosophila Ufd2, just
downstream of the MPAC regulatory region [28]. Alignment of
this extended muscle-specific sequence with genomic sequences
from human chromosome 1 (Accession NC_000001) demonstrat-
ed the presence of 2 additional exons in the muscle-specific
isoform that were 387 bp and 153 bp in length (Fig. 2A); both
exons maintained the open reading frame. The 387-bp sequence
corresponding to exon 7 was originally found in a UFD2a cDNA
clone derived from a human fetal brain cDNA library, entered
into the NCBI database in 1998 (Accession AF043117), and later
was referred to as transcript variant 1 (RefSeq Accession
NM_001105562). However, when we cloned UFD2a from HeLa
cell cDNA, exon 7 was not present (RefSeq Accession
NM_006048) [24]. We will hereafter refer to the UFD2a isoform
containing exon 7 spliced to exons 6 and 8 as UFD2a-7.
Interestingly, two recent genome-wide exon-junction and whole
transcript microarrays, which examined the expression of
alternative pre-mRNA splice forms across a total of 92 tissues
and cell lines, both found that exon 7 was not present in UFD2a
cDNA from human fetal brain tissue. In fact, consistent with the
data presented here, exon 7 was exclusively expressed in adult
human skeletal muscle, heart, tongue (therefore, predominantly in
striated muscle cells) and to a lower extent peripheral blood
leukocytes. Of the nine fetal tissues tested, only fetal heart
expressed exon 7 (fetal skeletal muscle was not included) [1,2].
Since the 153-bp exon has not yet been reported, we termed this
novel exon, which immediately follows exon 7 in muscle
transcripts, exon 7a. Exons 7 and 7a are flanked by canonical
splice-donor and -acceptor sequences. As a result of the inclusion
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we have termed UFD2a-7/7a (submitted to Genbank, Accession
JF289274), contains 180 additional amino acids (Fig. 2B).
Conservation and tissue specificity of UFD2a-7 and
UFD2a-7/7a in vertebrates
To examine the tissue specificity of UFD2a-7 and -7/7a, we
prepared protein extracts from various murine tissues and
analyzed their expression via Western blot. Among the 9 tissues,
only the heart, tongue, and skeletal muscle contained the
approximately 163-kD UFD2a-7/7a form (Fig. 3A). These tissues
also appeared to contain a variable amount of ubiquitous UFD2a,
though this result is likely due to the presence of nonmuscle cells
(e.g., fibroblasts and erythrocytes) in the dissected tissues. As
shown previously, UFD2a expression was almost absent in the
kidney [25].
Embryonic striated muscle development is easily viewed in
zebrafish, and morpholino oligonucleotides have been used
extensively in this organism to examine the significance of
alternative transcripts. Thus, we sought to determine whether
UFD2a-7 and -7/7a are expressed in zebrafish. RT-PCR was
performed on RNA extracted from whole zebrafish at 7 days
postfertilization (dpf) by using primers F1 and R1, which flank the
predicted locations of exons 7 and 7a (Fig 3B), according to ube4b
(UFD2a ortholog) nucleotide entries NP_919343 and
NM_194362. Most of the resulting cDNA product was 333 bp,
representing the amplification of the ubiquitous form of ube4b
contained within this primer set; this product did not contain
exons 7 and 7a (Fig. 3C). However, there was also a faint, larger
(873 bp) band present that presumably corresponded to the
inclusion of exons 7 and 7a predicted via homology to mammalian
UFD2a exons (Fig 3C).
The tissue specificity of the Ube4b isoform containing exons 7
and 7a was examined by RT-PCR using primer R2 (Fig 3B) and a
primer specific for the newly identified exon 7. Among brain,
spleen, skeletal muscle, heart (shown in Fig 3D), testes and liver
(not shown) extracted from multiple adult fish, a product
containing exon 7 and 7a was only obtained from skeletal muscle
and heart cDNA, suggesting that the tissue specificity of these
exons are conserved in zebrafish.
The intron downstream of exons 7 and 7a contains two
conserved motifs associated with exons upregulated in
striated muscle
Multiple sequence alignments of exons 7 (not shown) and 7a
(Fig. 4A) from 9 vertebrate species revealed a high degree of
sequence identity. In exon 7, the main variability was seen in a
slightly degenerative repeat region in mice that is not present in
the other organisms examined. Variation within exon 7a existed
mainly in the length of a highly acidic, low-complexity central
core, primarily composed of aspartic acid, glutamic acid, serine,
and glycine. Sequences flanking this central core were more highly
conserved.
Figure 1. A larger isoform of UFD2a is specifically expressed in striated muscle. A). Protein lysates were prepared from normal human
tissues and human salivary gland cells (HSG) that were untreated (-) or arrested in mitosis (+Noc) and subjected to SDS PAGE. After transfer to
nitrocellulose, samples were analyzed by immunoblotting using a rabbit polyclonal antibody recognizing UFD2a. A 97-kDa band visible in many
muscle lysates and some other tissues represented cross-reactivity to phosphorylase b (not shown). B). UFD2a-7/7a expression in cardiac muscle (Hrt)
but not coronary artery (CA) from an explanted human heart (3 patient samples were analyzed; 1 is shown here). C). Human skeletal muscle (Sk Mu)
lysates and lysates made from human HeLa cells arrested in mitosis (M) with nocodazole were treated with lprotein phosphatase (lppase).
Interphase (I) and untreated mitotic (M) HeLa cells are shown for comparison; phos refers to the phosphorylated form of UFD2a. Top and bottom
panels represent different exposures of the same Western blot to account for the difference in the UFD2a levels in total protein from cell cultures
compared to human tissue. D).Total RNA from human skeletal muscle (Hu SkM), K562 human erythroleukemia cells, and primary human monocyte-
derived macrophages (Hu Mac) were used as templates for cDNA reactions. RT-PCR analyses were performed using primers recognizing a portion
from the 59-end of UFD2a (upper panel), the 39-end of UFD2a (middle), or from the housekeeping gene HPRT (lower). The 59 UFD2a primers amplified
the expected 830-bp fragment from other tissues and the novel 1217-bp and 1370-bp fragments in muscle.
doi:10.1371/journal.pone.0028861.g001
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computational techniques have begun to elucidate patterns in
the expression of alternatively spliced genes. A study by Sugnet,
et al [33] showed that many alternatively spliced exons that are
preferentially expressed in muscle tissue exist upstream of a novel
sequence motif, CTAAC, within the first 150 nucleotides of the
downstream intron. A similar analysis of alternative splicing events
occurring during myogenic differentiation identified ACTAAC as
a regulatory sequence, which is conserved in introns flanking
alternatively spliced exons in 7 mammalian species [4]. Examina-
tion of the intron downstream of UFD2a exon 7a revealed 2 exact
matches to these motifs, nearly in tandem, approximately 50 bp
downstream of the splice donor (Fig. 4B).
Another recent screen investigated the presence of regulatory
motifs enriched in introns adjacent to alternatively spliced exons
among tissue-specific, alternatively spliced genes in humans. In this
study, the TGCATG (FOX-1) motif was highly enriched 10 to
80 nts downstream of skeletal muscle and heart specific exons with
limited or no expression in other tissues (p,10
216) [1]. The
introns downstream of both exon 7 (not shown) and 7a (Fig 4B) in
the human UFD2a sequence contain a TGCATG FOX-1 motif at
position+21 and 26 respectively. This sequence was not present in
any other 39-intronic regions, suggesting the specificity of this
motif for directing the alternative splicing of these exons.
If muscle-specific alternative-splicing motifs are required to
maintain accurate muscle-specific expression patterns, then there
would be selective pressure to maintain those motifs across species.
Thus, we used CLUSTALW [34,35] to align across 5 vertebrate
species the sequences downstream of exon 7a (Fig. 4B). Among the
UFD2a genomic sequences analyzed, a copy of the ACTAAC
motif was located about 50 bp downstream of the end of exon 7a;
the TGCATG motif was found in 4 of the 5 species but was not
present in zebrafish. In addition, examination of all of the 39-
flanking intronic regions (100 nts) within the UFD2a genomic
sequence across the 5 species revealed that the ACTAAC motif
occurred only 6 additional times, and the specific intron in which it
was found was not conserved. This suggests that the presence of
the ACTAAC motif in other introns was not under selective
pressure and may be a result of random assortment. Also, the
intronic sequences, with the exception of these 2 motifs, were
poorly conserved among the species as expected.
Expression of UFD2a-7 and UFD2a-7/7a are sequentially
induced upon muscle differentiation
Mature muscle tissue is generally postmitotic, where little or no
cell division is detected in mature myofibers. Replacement of
damaged or senescent muscle fibers occurs by proliferation and
differentiation of satellite cells, a tissue-resident muscle cell
precursor population (for reviews: [36–37] and [38]). We
previously showed that UFD2a plays a central role in mitotic
progression [23]; thus, we investigated whether UFD2a, UFD2a-7,
Figure 2. Positions of the muscle-specific exons. A). This map shows the locations of the 29 exons of the human UFD2a gene spread across
approximately 200 kb near the telomere on the short arm of chromosome 1. Ubiquitous exons are shown in black. Exon 7, which has been found in
fetal brain and striated muscle, is shown in blue. The striated muscle–specific exon 7a is show in red. B). Illustration of the UFD2a protein showing
positions of the MPAC domain, catalytic U box, exons 7 and 7a, and the region conserved in lower eukaryotes (light green).
doi:10.1371/journal.pone.0028861.g002
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during muscle cell maturation.
Differentiation of the C2C12 murine myoblast cell line is a well-
established model of maturation from myoblasts to myotubes
[39,40]. Only the ubiquitous isoform of UFD2a was expressed in
the dividing myoblasts (Fig. 5A; days 0–1). Interestingly, upon
differentiation, 2 larger (by apparent MW) isoforms were
sequentially induced. Specifically, UFD2a-7 appeared at very
low levels by Day 2 and increased by Day 3, while UFD2a-7/7a
appeared at Day 3 and increased on subsequent days (note that
equal total protein loading across lanes is shown in Fig S1).
Induction of these larger isoforms occurred with timing similar to
the appearance of mature muscle markers such as myosin heavy
chain (MHC), muscle-specific a-sarcomeric actin, and creatine
phosphokinase (Fig. 5A and data not shown). In addition, RT-
PCR using a forward primer spanning the junction between exons
6 and 7 with a reverse primer spanning exons 7 and 8 showed that
transcripts containing only exon 7 (UFD2a-7) were apparent at
appreciable levels in undifferentiated cells (Days 0–1) and then
greatly increased at days 3 and 4, when the cultures contained
multinucleated myotubes (Fig. 5B; top panel). In contrast, use of a
reverse primer specific for the junction between exons 7a and 8 in
conjunction with the previous exon 6–7 junction forward primer
showed that transcripts containing 7a are present at very low levels
until Day 3 (Fig. 5B; middle panel). RT-PCR using primers
specific for exons 19 and 20 revealed that the total amount of
UFD2a transcripts (all three isoforms) appeared to be relatively
equal at all time points (Fig. 5B, bottom panel).
In contrast with mature muscle tissue, differentiating C2C12
cells expressed the intermediate-sized isoform, UFD2a-7. When
maximal differentiation into myotubes occurred (Day 5), only
about 30% of the total UFD2a protein expression consisted of the
upper 2 isoforms corresponding to UFD2a-7 and -7/7a (Fig. 5A
top panel). However, the continued expression of myogenin
(Fig. 5A), a bHLH family transcription factor important in
myoblast development [41], provided evidence that this system
does not lead to fully mature myofibers. Therefore the data show
that UFD2a-7 expression precedes that of UFD2a-7/7a and
suggests that it may occur transiently during differentiation, while
the exclusive expression of UFD2a-7/7a is a late event in
myogenesis, occurring at a stage that cannot be replicated in
C2C12 cell cultures.
Quantitative RT-PCR showed that at the mRNA level, the
UFD2a-7/7a isoform was detectable in the undifferentiated
C2C12 mouse myoblasts but was induced approximately 10-fold
upon differentiation into myotubes (Fig. 5C). Total UFD2a
mRNA, representing isoforms with or without exons 7 and 7a,
remained relatively constant. As expected, a-sarcomeric actin was
Figure 3. Expression of the muscle-specific alternative isoforms of UFD2a is conserved in mice and zebrafish. A). Among 8 murine
tissues, UFD2a-7/7a is expressed only in striated muscle. Protein lysates prepared from adult murine tissues analyzed by immunoblotting using a
rabbit polyclonal antibody recognizing UFD2a. B). Schematic diagram depicting the exons of zebrafish ube4B (UFD2a ortholog) and the location of
various primer sets used for RT-PCR. C). RNA was extracted from whole 7 pfd zebrafish embryos and subjected to RT-PCR analysis using primers F2
and R2. The 333-bp band represents the fragment expected from the amplification of exons 6, 8, and 9, and the 873-bp fragment includes
amplification of the suspected exons 7 and 7a. D). RNA extracted from 4 tissues from multiple adult zebrafish was analyzed by RT-PCR using primers
F2 (specific for exon 7) and R2 (exon 8).
doi:10.1371/journal.pone.0028861.g003
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while the expression of muscle-specific E3 ligase atrogin-1/MAFbx
mRNA was unchanged. The finding that UFD2a-7/7a message
was detectable in undifferentiated C2C12 myoblasts implies that
the expression of UFD2a-7/7a protein may also be subject to
translational control, as previously shown for the muscle-specific
transcription factor MyoD [11]. Alternatively, UFD2a-7/7a may
be rapidly degraded in proliferating myoblasts, thereby leading to
steady-state protein levels too low for detection by Western
blotting.
UFD2a isoform expression is regulated in a mouse model
of muscle regeneration
To probe the regulation of UFD2a isoforms in response to
muscle damage in vivo, we used the cardiotoxin (CTX) model of
muscle degeneration/regeneration in mice [42]. CTX, a cobra
venom peptide, is a pore-forming toxin that potently targets
muscle cells. We injected the toxin along the entire length of the
tibialis anterior (TA) muscle of mice and then allowed the animals
to recover for various times. Muscle tissue was then harvested from
the injected and contralateral untreated limbs. Consistent with our
previous findings in mature mice, UFD2a-7/7a was the predom-
inant isoform expressed in the untreated TA muscle (Fig. 1A). As
previously reported, the injected TA muscle underwent transient
degeneration, followed by regeneration, and return to the
preinjected state [42]. In untreated muscle, UFD2a-7/7a was
the predominant isoform expressed, consistent with our previous
findings in mature mouse muscle (see Fig. 1A). Two days after
CTX injection, expression of the mature muscle-specific UFD2a-
7/7a isoform was undetectable, and that of the short isoform of
UFD2a, which is expressed ubiquitously and in immature
myoblasts, was markedly increased (Fig. 6A). Five days after
CTX injection, UFD2a-7 and UFD2a-7/7a expression returned,
and by 12 days, UFD2a-7 was almost undetectable, suggesting
that UFD2a-7 is in fact a transient alternative splice form that may
be important during the differentiation process. This switch in
UFD2a isoform expression mirrored that of MHC, a well-known
marker of mature muscle tissue. The transcription factor Myf5,
which is expressed only in proliferating myoblasts, was not
detected prior to injection, was induced at 2 to 5 days
postinjection, and then returned to undetectable levels within 12
days, presumably upon completion of regeneration. These studies
Figure 4. UFD2a exon-7a is highly conserved across vertebrates and contains conserved motifs associated with muscle-specific
alternative splicing. A). Alignment of exon 7a amino acid sequence. Asterisks indicate complete conservation across all species, and colons
indicate strong conservation. Negatively charged residues are shown in blue, and hydrophobic residues are shown in red. B). Alignment of the 39-end
of exon 7a plus the first 100 bp of the following intron. The splice donor site is shown in blue. The CTAAC putative muscle-specific alternative
splicing signal is shown in red. The TGCATG Fox motif enriched in introns of striated muscle exons is shown in purple. Residues identical in all
sequences are marked with an asterisk. The amino acid sequence of human exon 7a is shown above.
doi:10.1371/journal.pone.0028861.g004
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the carefully regulated process of muscle regeneration.
Sequential expression of UFD2a-7 and UFD2a-7/7a
occurs during development
Since the molecular mechanisms that regulate adult myoblast
differentiation are thought to be similar to those that regulate
embryonic myogenesis, we analyzed UFD2a isoform expression
during development in murine heart and skeletal muscle. As in
differentiating myoblasts, the pattern of UFD2a alternative splice
isoform expression appeared sequential, i.e., UFD2a-7 was
expressed before UFD2a-7/7a. However, the ultimate switch to
UFD2a-7/7a occurred much sooner in cardiomyocytes than in
skeletal muscle. At embryonic day (E) 14, when primary skeletal
muscle fibers have been established, Western blot analysis detected
no UFD2a-7 or -7/7a protein in murine skeletal (Fig. 6B upper
panels) or cardiac muscle tissue (Fig 6B lower panels). In skeletal
muscle, UFD2a-7 was not detectable until E18, when secondary
skeletal muscle myofibers were fusing. At P1, both UFD2a-7 and
UFD2a-7/7a could be detected, as seen by the doublet in both
tissue sets. By P7, UFD2a-7 was reduced and UFD2a-7/7a
isoform dominated. Only a faint UFD2a-7 band was seen at E16,
Figure 5. UFD2a-7 and UFD2a-7/7a mRNA and protein expression are upregulated during differentiation and regeneration. A).
C2C12 cells were plated in growth medium overnight and then transferred into differentiation medium (DM). Cell cultures were harvested for analysis
after the indicated times. Equal total protein was loaded on SDS-PAGE (see Figure S1 for poneau S staining) and analyzed for expression of the
indicated proteins. The UFD2a panel was performed on a large-format 6% bis-acrylamide gel for greater separation of the 2 larger UFD2a isoforms
and probed with the 15041 polyclonal antibody, which recognizes all isoforms. B). C2C12 cells were plated in growth medium overnight and then
transferred into DM. Cell cultures were harvested for analysis after the indicated times. Total RNA was isolated using TRIzol and used as a template for
RT-PCR. PCR was performed on the resulting cDNA (made with or without reverse transcriptase (RT)) using a 59 primer complementary to exon 6 and
a3 9 primer specific for either the exon 7/exon 8 junction (top panel) to detect UFD2a-7 transcripts or the exon 7a/exon 8 junction (middle panel) to
detect UFD2a-7/7a transcripts. Primers specific to exon 19 and 20 were used in the bottom panel to show total UFD2a transcripts. C). Total RNA was
isolated with TRIzol from duplicate samples of cells used in panel A and subjected to RT-PCR. Quantitative PCR was performed in duplicate using
TaqMan primers that recognized the indicated transcripts. Transcript expression data, normalized to the expression of HPRT, are expressed relativet o
the expression level at time zero. Error bars indicate standard deviation.
doi:10.1371/journal.pone.0028861.g005
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UFD2a-7/7a expression, in contrast to skeletal muscle where
UFD2a-7/7a expression did not become apparent until postnatal
day (P1) .At all developmental time points tested, significantly
more ubiquitous UFD2a isoform was present than was found in
adult muscle tissue, which most likely indicates that myoblasts (in
skeletal muscle) and other contaminating cells types (e.g.,
endothelial cells and fibroblasts) were actively dividing as the
tissues continued to grow and develop. While the expression
patterns discussed above were robust in western blots performed
using samples from multiple mice, It was noted that there was
some variability in the relative levels of each isoform detected at
individual developmental time points. Therefore, a second set of
skeletal muscle and heart tissue samples is shown in Figure S2.
To examine whether the sequential transition from Ufd2a-7 to
UFD2a-7/7a during development is conserved, we examined the
pattern of ube4b mRNA expression during early development in
zebrafish by using RT-PCR. We specifically examined the mRNA
expression pattern of ube4b, rather than protein levels, because
neither rabbit polyclonal nor mouse monoclonal antibodies
specifically recognized zebrafish Ube4b by Western blotting (as
tested on in vitro transcribed and translated flag-tagged Danio rario
UBE4B proteins, data not shown). Nested PCR performed on the
purified products obtained from 10-, 12-, 24-, and 48-hpf (hours
postfertilization) embryos and 7-dpf embryos using primers F1 and
R1 followed by F2 and R2 (Fig. 3B) revealed that more of Ufd2a-7
was present at the earlier developmental stages (10 hpf –12 hpf)
(Fig. 6C). These 2 nested PCR products were sequenced and
blasted against the NCBI zebrafish ube4b genome. An identical
match was found with 2 sequences within what had been
previously considered intronic sequence in the zebrafish UFD2a
ortholog. These results confirmed that the smaller amplicon was
consistent with Ube4b-7, and the larger amplicon seen in increasing
amounts from 12 hpf to 7 dpf represented the larger Ube4b-7/7a
isoform. We have entered the two novel Ube4b isoforms in
Genebank and the accession numbers: JF289275 (zebrafish
UFD2a-7) and JF289276 (zebrafish UFD2a-7) have been assigned.
Interestingly, during the period between 10 hpf and 24 hpf,
zebrafish somites and heart are forming, such that by 24 hpf a
beating heart can be observed. These data provide evidence for
the expression of both alternative splice forms of Ube4b during
this period of zebrafish development in a sequential pattern like
that seen in mammalian myogenesis.
Muscle-specific UFD2a-7/7a fails to interact with VCP/p97
We hypothesized that the binding specificity of the muscle-
specific isoform is altered from that of the ubiquitous UFD2a.
UFD2a homologues in yeast, worms, and mice interact with the
AAA-type ATPase VCP/p97 (cdc48 in yeast) [1,23,24], which
functions in mitotic progression, muscle myofibril organization,
and myoblast fusion [24–26]. Therefore, we sought to determine
whether UFD2a-7/7a binds to VCP/p97 in a yeast 2-hybrid
assay.
Mav203 yeast containing Gal4-regulated HIS3 and lacZ genes
were co-transformed with plasmids coding for a bait protein
consisting of the Gal4 DNA binding domain fused to either UFD2a
or UFD2a-7/7a (pDEST32-UFD2a or pDEST32-UFD2a-7/7a)
and a prey protein consisting of the Gal4 activation domain fused
to VCP/p97 (pDEST22-VCP/p97). Yeast co-transformed with
these plasmids were selected on double drop out medium and
expression of the fusion proteins was confirmed by Western blot
(Figure S3). Control yeast clones expressing the bait or prey
proteins alone were co-transformed with empty pDEST32 or
pDEST22.
Only yeast coexpressing UFD2a and VCP/p97 fusion proteins
grew on medium lacking histidine in the presence of 3-
aminotriazole, a histidine biosynthesis inhibitor, indicating an
Figure 6. Expression of UFD2a alternative-splice forms occurs
sequentially during regeneration and developmental myogen-
esis. A). Mice received intramuscular injections of cardiotoxin (CTX) in
the right tibialis anterior muscle. After the indicated number of days of
recovery, the treated and untreated contralateral muscles were
harvested and analyzed by immunoblotting for UFD2a, the mature
muscle marker myosin heavy chain (MHC), the proliferating myoblast
marker Myf5, myogenin, MyoD, and vinculin as a loading control. The
inset at right shows the exposure from a low-bis gel in which the
UFD2a-7 isoform of intermediate size is more clearly separated from
UFD2a-7/7a at Day 5 and more clearly shows its absence at Day 12
(arrows point to the two isoforms). B). Skeletal muscle (upper panels;
pooled gastrocnemius, soleus, and quadriceps muscles) or hearts (lower
panels) from E14, E16, and E18 embryos and P1 and P7 pups were
dissected from individual embryos or pups at each time point and
analyzed by Western blotting for UFD2a (note a second set of mice are
shown in Fig S2). Adult mouse heart (H), skeletal muscle (SkM), and
spleen (Sp) were simultaneously analyzed for comparison. C). RNA was
extracted from whole zebrafish embryos at 10, 12, 24, and 48 hpf, and
nested PCR was performed using primers F3 and R3 on the 873- and
756-bp fragments produced from the initial RT-PCR.
doi:10.1371/journal.pone.0028861.g006
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contrast, neither yeast coexpressing UFD2a-7/7a and VCP/p97
fusion proteins nor yeast expressing bait or prey proteins alone
grew in this medium (Fig. 7A). The lack of interaction between
UFD2a-7/7a and VCP/p97 was confirmed by the absence of b -
galactosidase activity in a liquid assay (Fig. 7B).
Discussion
We describe here 2 muscle-specific alternative splice forms of
the ubiquitin ligase, UFD2a. The smaller, UFD2a-7 contains the
previously identified exon 7, while UFD2a-7/7a incorporates a
novel exon 7a in addition to exon 7. Both of these alternatively
spliced exons are located just downstream of the previously
described MPAC regulatory domain and within the N-terminal
extension of UFD2a, which is unique to vertebrate orthologs [28].
The GenBank database includes expressed sequence tag entries
containing exon 7 spliced to exon 8 in human primary fibroblasts
and thalamus tissue [43], and a full-length cDNA sequence of
UFD2a-7 cloned from a mouse fetal brain library. However, we
did not detect UFD2a-7 protein in human or mouse fibroblast or
brain tissues. Two recent genome-wide exon-junction and whole
transcript microarrays, which examined the expression of
alternative pre-mRNA splice forms across a total of 92 tissues
and cell lines, both found that exon 7 was not present in UFD2a
cDNA from human fetal brain tissue. In fact, consistent with the
data presented here, exon 7 was exclusively expressed in adult
human skeletal muscle, heart, tongue (therefore, predominantly in
striated muscle cells) and to a lower extent peripheral blood
leukocytes. Of the nine fetal tissues tested, only fetal heart
expressed exon 7 (fetal skeletal muscle was not included). The
tissue specificity of exon 7a was not examined since its presence in
UFD2a had not yet been reported.
Our RT-PCR and Western blot data suggest that UFD2a-7 is
uniquely expressed in a transient manner during myogenic
development and myoblast differentiation. The timing of
UFD2a-7 expression during differentiation and after injury
appeared to correlate with that of the myogenic regulatory factors
Myf5 and MyoD. Interestingly, ubiquitin-dependent degradation
regulates most of these myogenic regulatory factors during
myogenesis. The degradation of Myf5, in particular, is required
for myoblast fusion [44] which occurs at the time of UFD2a-7
expression. In developing skeletal muscle, it coincided with the
greatest expression of embryonic MHC (data not shown).
In cell culture models of differentiation and in vivo models of
regeneration, UFD2a and UFD2a-7 protein persisted, most likely
because differentiation was not complete. However, UFD2a-7 was
not present in adult striated muscle tissue in vivo, and though small
amounts of the ubiquitous UFD2a isoform were detected in tissue
lysates, only UFD2a-7/7a was seen on Western blots of isolated
EDL muscle fibers (data not shown). Therefore, UFD2a-7
expression is transient during muscle differentiation, a phenom-
enon which is mirrored during development, where UFD2a-7 was
detected in both embryonic tissue from mice and zebrafish but
disappeared by 7 days after birth.
The newly identified UFD2a-7/7a isoform was expressed with
slightly delayed kinetics during differentiation in vitro and during
regeneration and development in vivo, where its levels increased
with time while UFD2a-7 decreased. Therefore, in both in vitro and
in vivo models of myogenesis, the UFD2a alternatively spliced
transcripts are expressed sequentially. The ubiquitous short
isoform is likely expressed in dividing myoblasts due to its role in
mitosis, while the transient expression of UFD2a-7 may be
important for transitory events during differentiation such as
myoblast fusion. Since expression of UFD2a-7/7a occurs late, it
may have a unique function in terminal differentiation. Identifi-
cation of the alternative splice form of Integrin a7b1, which
appears late in differentiation [4], provides evidence that splicing
can influence processes required for differentiation since a7b1
isoform specific protein-protein interactions regulate myotube
formation and cell adherence in culture [45]. The fact that
UFD2a-7/7a did not bind to VCP/p97 suggests that UFD2a
alternative splice forms also have different binding specificities,
strongly suggesting a unique function for UFD2a-7 and -7/7a in
differentiated muscle cells.
Although several other muscle-specific ubiquitin E3 ligases have
been identified, including F-box (MAFbx)/atrogin-1 and the
muscle-specific RING finger (MURF) family, and their impor-
Figure 7. The muscle-specific UFD2a-7/7a isoform does not interact with VCP/p97. A). Yeast cells transformed with bait plasmids pDEST32-
UFD2a, pDEST32-UFD2a-7/7a, or empty pDEST32 and prey plasmids pDEST22-VCP/p97 or empty pDEST22 were grown in liquid double dropout
medium (-leu, -trp) to saturation and diluted to an OD600 of 1. Serial dilutions of these cell cultures were prepared in 96-well plates and transferred to
triple-dropout agar plates (-leu, -trp, -his) supplemented with 25 mM 3-AT. B). Isolated colonies of yeast cells transformed (as in panel A) were grown
to saturation, diluted to OD600 of 0.3, and grown to log phase (OD600=0.8-1.5). Cells were disrupted with glass beads in Z buffer; ONPG substrate and
b-mercaptoethanol were added to the resulting supernatants. After incubation at 37uC, supernatants were transferred to 96-well plates and read at
420 nm. B). Relative b-galactosidase activity is calculated from 6 independent experiments; error bars indicate standard error. The average activity of
UFD2a+VCP/p97 was significantly higher than that of the other transformants (*p=0.02). The activity of UFD2a-7/7a+VCP/p97 did not differ from that
of the negative controls.
doi:10.1371/journal.pone.0028861.g007
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[46,47,48], UFD2a is unique in that it represents a ubiquitously
expressed ligase that has distinct alternative-splice forms in striated
muscle. The central section of the exon 7a sequence is unusually
rich in acidic amino acids. Although the length of this acidic
sequence is variable among species, its presence is conserved. This
finding suggests that the exon contains a unique binding domain
that mediates interaction with a positively charged molecule.
Interestingly, the N-terminal domain of UFD2a contains an
RRRL motif, which mediates its interaction with VCP/p97. In
fact, the yeast 2-hybrid data presented here showed that UFD2a-
7/7a fails to bind VCP/p97, suggesting that the acidic stretch of
exon 7a may disrupt UFD2a folding, affecting this interaction.
One striated muscle protein whose proteasome-dependent
degradation depends on UFD2a and VCP/p97 is UNC-45b
[19,49]. C. elegans contains only one unc-45 gene, but vertebrates
express UNC-45a (also referred to as the General Cell (GC) form) in
most tissues and UNC45b exclusively in striated muscle tissue [50].
UNC-45 proteins have myosin chaparonin activity which under
certain conditions may involve forming a co-chaperone complex
with HSP-90 [17,51,52], however recent studies in C. elegans suggest
that UNC-45 function in muscle is inhibited by HSP-90 binding
[53] UNC-45a appears to be essential to basic cellular processes
such as cytokinesis, myoblast proliferation, and early fusion events,
and UNC-45bis required for proper assembly ofsarcomeric myosin
filaments [17,18,50,54,55,56]. Interestingly, the expression of
UNC-45 isoforms mirrors those of UFD2a, where UNC-45a is
expressed early during differentiation, and later its levels decrease
while those of UNC-45b increase [50]. The degradation of human
UNC-45b has been shown to be dependent upon human UFD2a
and VCP/p97 [49], but the mechanism of UNC-45a degradation
has not been studied. Potentially, UFD2a may not target UNC-45a
for degradation, thereby allowing levels of this isoform to remain
high during myoblast proliferation. However, at this time and
during early stages of differentiation, UFD2a may ubiquitinate
UNC-45b and target its degradation in a manner dependent on its
interaction with VCP/p97. The importance of the regulation of
UNC-45b levels is illustrated by the detrimental effects of UNC-45b
overexpression. Increased Unc-45b in zebrafish results in disorga-
nized myosin filaments [57], and overexpression of Unc-45 in
worms leads to paralysis [18]. Later in differentiation, levels of
UFD2a decrease concomitant with an increase in UFD2a-7 and -7/
7a, the latter of which may not bind to VCP-p97, promoting UNC-
45b degradation and subsequent accumulation of this vital
chaperone. Moreover, UFD2a-7 may specifically target UNC-45a
after the early myoblast fusion events have completed.
Like UFD2a,VCP/p97has been implicated in the progression of
cells through mitosis, a process that would be restricted to
proliferating myoblasts, which express UFD2a-7. When VCP/p97
is bound to the UFD1-Npl4 cofactor complex, it extracts
ubiquitinated Aurora B kinase from mitotic chromosomes, a
process that is essential for decondensation, nuclear reformation,
and spindle disassembly [58,59]. If VCP/p97 were to interact with
the UFD1-Nlp4 complex and UFD2a in a mutually exclusive
fashion, UFD2a binding may inhibit premature extraction of
Aurora B. The fact that both UFD2a and VCP/p97 are required
for mitotic progression suggests that their interaction may be
important only during myoblast proliferation. Later in differentia-
tion, when myocytes have exited the cell cycle, the switching of
UFD2a isoform expression to UFD2a-7/7a may promote complete
differentiation bysimplyenablingVCP/p97tobind othercofactors.
The differential binding of UFD2a and UFD2a-7/7a to VCP/
p97 is also of interest given that mutations in this AAA-type
ATPase are present in patients with inclusion body myopathy
associated with Paget’s disease of bone and frontotemporal
dementia and cause complete disease pathology in transgenic
mice [60,61]. In vitro studies have suggested that VCP/p97 is
crucial for homeostasis in mature muscle and during differentia-
tion. Indeed, expression of disease-associated mutant VCP/p97
leads to an accumulation of ubiquitin-loaded autophagosomes and
decreased myoblast fusion [62,63].
In summary, the data reported here show that 2 alternatively
spliced isoforms of the E3/4 ubiquitin ligase UFD2a, resulting
from the inclusion of 2 exons highly conserved across vertebrate
species, are specifically expressed in differentiating or mature
striated muscle cells. Intron sequences immediately downstream of
these muscle-specific exons contain recently described sequence
motifs thought to convey muscle-specific alternative splicing.
Given the sequential nature of isoform expression during zebrafish
development and mammalian skeletal muscle differentiation and
regeneration, we hypothesize that UFD2a-7 participates in key
events of early myoblast differentiation, including the first cell-
fusion event, and UFD2a-7/7a maintains the postmitotic state in
mature muscle. We postulate that the differential binding capacity
of these UFD2a isoforms to the ubiquitin-binding chaperone
VCP/p97 is important to the regulation of UFD2a function
during this process. These data are the first to suggest that UFD2a
has divergent functions in striated muscle tissue and that
elucidation of these functions during myocyte differentiation and
physiology may provide further insight into the mechanisms of
muscle regeneration and response to injury and disease.
Materials and Methods
RT-PCR
Total RNA was prepared from cells maintained in culture,
murine tissues, and tissues extracted from male and female
zebrafish (1–1.5 years old) or whole snap-frozen zebrafish embryos
by using TRIzol (Invitrogen, Carlsbad, CA). RNA was converted
to cDNA by using standard techniques. Human skeletal muscle
total RNA was purchased (Stratagene, Santa Clara, CA). Aliquots
of the cDNA were used as the template for PCR using a variety of
primers specific for human UFD2a, murine Ube4b, or zebrafish
ube4b sequences. HPRT served as a positive control. See table 1 for
all primer sequences used.
Identification of exon 7 and 7a in zebrafish Ube4b
Total RNA was purified from zebrafish embryos at 10, 12, 24,
and 48 hpf and 7 dpf. The cDNA was amplified using an oligodT
primer (Invitrogen). Nested PCR was performed using 2 primer sets
complementary to the end of exon 6 and beginning of exon 8 or 9
(according to NCBI accession AY029484). The inner primer pair
contained HindIII restriction sites. PCR fragments were inserted
into Blueskript SK(+) and sequenced (pBLUE-DR1 and pBLUE-
DR2). Sequence data were blasted against the D. rerio genome
database to confirm their localization withintheUbe4b open reading
frame on chromosome 23. See table 1 for all primer sequences.
Quantitative PCR
QuantitativePCRreactionswereperformedusingcDNAsamples
prepared as described above and TaqMan primer/probe sets.
Prevalidated primer/probe sets (Applied Biosystems) were used for
UFD2a (Mm00502528_m1), a-actin (Mm00808218_g1), MAFbx/
Fbxo32 (Mm00499518_m1), and HPRT (Mm00446968_m1). The
UFD2a primer/probe set targeted sequences within exon 9 and thus
recognized all isoforms. A custom primer/probe set was used for
UFD2a-7/7a. These sequences cross the exon 7/7a junction; thus,
they recognize only transcripts containing both exons 7 and 7a.
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expression of HPRT by using the DDCt method and was plotted
relative to expression of that gene at time zero. See table 1 for all
primer sequences.
Western blotting
Lysates of cells in culture were prepared by scraping the cells
into lysis buffer (10 mM Tris HCl, pH 7.6, 1% NP-40, 2 mM
EDTA, 150 mM NaCl), supplementing the medium with 1 mg/
mL pepstatin, leupeptin, antipain, and chymostatin and 1 mM
phenylmethylsulfonylfluoride or 16protease inhibitor cocktail
(Pierce Chemicals, Rockford, IL). Tissue lysates were prepared
by finely mincing tissue with a razor blade and then lysing it in a
glass/Teflon homogenizer. Crude lysates were centrifuged for
10 min at 14,000 x g at 4uC, and the resulting supernatants were
assayed for protein content. Cell and tissue lysates were treated
with l-protein phosphatase, according to the manufacturer’s
protocol, for 30 min at 30uC. Equal amounts of protein were
electrophoresed on SDS-PAGE gels and then transferred to
nitrocellulose membranes. UFD2a was detected using a polyclonal
antibody that recognizes the N-terminal MPAC domain of UFD2a
[28]. Other antibodies were from commercial sources: MHC
(MF20, Developmental Studies Hybridoma Bank, University of
Iowa, Iowa City, IA), a-sarcomeric actin (5C5, Sigma, St. Louis,
MO), b-actin (AC-74, Sigma), myogenin (M-225, Santa Cruz
Biotechnology, Santa Cruz, CA), Myf5 (C-20, Santa Cruz
Biotechnology), vinculin and sarcomeric actin (Sigma), and b-
tubulin (TUB 2.1, Sigma). Skeletal muscle tissue from E18 mouse
embryos, P1 and P7 pups consisted of pooled gastrocnemius,
soleus, and quadriceps muscles. That from E14 and E18 mice
included some bone and skin. Tissue from 2 embryos or pups were
collected at each time point and analyzed separately. Western
blots shown in the supplementary information were performed
using transformed yeast grown to log phase in –leu/-trp selective
media. Cell pellets were washed in 1 ml of 20% Tricloroacetic
acid (TCA), resuspended in 400 ml 20% TCA and 150 ml of acid
washed glass beads and vortexed at 4uC. Supernatants were
precipitated at 13 K and washed in 2% TCA. Protein pellets were
resuspended in 200 ml of 1x SDS-PAGE sample buffer containing
Tris base per original O.D600 of 2 and boiled. UFD2a and
UFD2a-7/7a bait proteins fused to the Gal4 DNA binding domain
(DB) were detected using a rabbit polyclonal antibody recognizing
the Gal4 DB domain (Santa Cruz Biotechnology). VCP/p97 fused
to the Gal4 activation domain (AD) was detected using a mouse
monoclonal antibody recognizing the AD (Clontech). As an
indicator of total protein loading the ATPase, Rpt5 was detected
using a rabbit polyclonal antibody (Abcam).
Human tissues
Deidentified frozen muscle biopsy samples were kindly provided
by Dr. Andrea Corse (Johns Hopkins University, Baltimore, MD).
De-identified frozen human heart and coronary artery samples
were from explanted hearts of heart transplant recipients and were
kindly provided by Dr. William Baldwin (Johns Hopkins
University). Tissue lysates were prepared as described above. All
human tissues used to make lysates were excess pathologic tissues
and were obtained without identifiers under Title 45 CFR
46.101(b): ‘‘Research on Human Specimens", National Institutes
Table 1. Primers used for PCR.
Organism Fig. Direction
Name/
Gene Applied Biosystems # Sequence
Human 1D Forward UFD2a GAGCATGGATATCGATGGTG
1D Reverse UFD2a GAGTGGTTCTCACCAGTTCC
1D Forward HPRT GCTGACCTGCTGGATTACAT
1D Reverse HPRT CCAGTTTCACTAATGACACAA
Mouse 5C UFD2a exon 9 Mm00502528_m1
5C Forward UFD2a exon7a Custom TCCTCCCTGCGGATCTCT
5C Reverse AGTTCGAGGAAGAGGAAGGAGAAA
5C alpha actin Mm00808218_g1
5C MAFbx/Fbxo32 Mm00499518_m1
5C HPRT Mm00446968_m1
5B 3
rd??? Forward UFD2a exon 6 CGAAGTCTAGACTGATTTTAAGGATCTGATTGGCC
5B 3
rd Reverse UFD2a exon 8 CATATCTCGAGCACTCGATGAGGTAGTTCG
5B 1
st &2
nd Forward UFD2a exon 6 CTAAGTCTAGACTTCAGCACCAGCTCGTTGTCTAG
5B 1
st Reverse UFD2a exon 7-8 jct* CATTACTCGAGCAGAGGCTCCCAAACTAGGAG
5B 2
nd Reverse UFD2a exon 7a-8 jct CATATCTCGAGGCTCCCAAACTGGACCCAAAC
5B 3rd Forward UFD2a exon 19 AGCTGATGCTGCGCATCCTGG
5B 3rd Reverse UFD2a exon 20 GGAGATGGAACATGTCCACGG
Zebrafish 3C-D Forward UBE4B F1 GTAACCCATTCGCCAGCCTGAC
3C-D Reverse UBE4B R1 ACAGCTGGTTGGCTGCACATC
5C Forward UBE4B F2 CTCATGATGTCCACCCGTTC
5C Reverse UBE4B R2 CAGTGGGAGCGAATGTTGCTC
*jct=junction.
+ +panels in figure 5B are 1–3 from top to bottom.
doi:10.1371/journal.pone.0028861.t001
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waived by the Johns Hopkins Institutional Review Board.
Mouse tissue
Adult tissues were harvested from two male and one female
C57Bl/6J mice, between 4 and 4.5 months of age. Lysates made
from each mouse were analyzed on three separate western blots.
This protocol (#38F-1) was approved by the Institutional Animal
Care and Use Committee at Rhode Island College. Embryos and
post-natal mice of various ages were harvested from timed-
pregnant C57Bl/6 female mice. Cardiac and skeletal muscle
(gastrocnemius, soleus, and quadriceps) was dissected from three
P7, P1, and E18 mice and embryos each, respectively. In order to
isolate the same skeletal muscle groups from E14 and E16
embryos, entire hind limbs (-hind paws) were dissected from three
embryos each, since skeletal muscle could not be distinguished
from skin or bone in embryos at this stage of development. All
mice were bred and maintained in accordance with the guidelines
set forth by the National Institutes of Health Guide for the Care
and Use of Laboratory Animals, published by the U.S. Public
Health Service. This experimental protocol (protocol number 506)
was approved by the Institutional Animal Care and Use
Committee at St. Jude Children’s Research Hospital.
Zebrafish Embryos
All protocols for zebrafish husbandry and collection of embryos
were approved by the Rhode Island College Institutional Animal
Care and Use Committee under protocol number 34Sp-1.
Muscle cell culture and differentiation
C2C12 mouse myoblasts were obtained from American Type
Culture Collection (Manassas, VA) or as a generous gift from Dr.
Robert Krauss (Mt. Sinai School of Medicine, New York, NY).
C2C12 cells were maintained in DMEM high-glucose medium,
supplemented with 10% fetal calf serum, 2 mM glutamine, 100
units/mL penicillin, and 100 mg/mL streptomycin. Differentiation
was induced by culturing in differentiation medium in which the
10% fetal calf serum was replaced with 2% horse serum or
16insulin/transferrin/selenium (10 mg/mL insulin, 5.5 mg/mL
transferrin, and 6.7 ng/mL selenium). Primary human myoblasts
(Cambrex, Walkersville, MD) were maintained in culture and
differentiated according to the supplier’s recommendations.
Cardiotoxin-induced muscle atrophy model
Six-week-old C57BL/6 mice were anesthetized with isoflurane;
the right legs were cleaned with alcohol; and the right TA muscles
were injected with 0.1 mL CTX (10 mM) (Calbiochem, San Diego,
CA)dilutedinPBS.ThecontralateraluninjectedTAmusclesserved
as controls. On Days 1, 2, 3, 5, and 12 post–CTX injections, the
mice were euthanized, and the bilateral TA muscles were removed.
The muscles were frozen rapidly in dry ice–cooled isopentane and
stored at –80uC. Samples were subsequently homogenized in lysis
buffer and analyzed by Western blotting. These experiments were
approved by the Johns Hopkins Animal Care and Use Committee,
which follows the National Research Council and National
Institutes of Health guidelines (protocol # MO06M41).
Yeast 2-hybrid experiments
The cDNAs of UFD2a or UFD2a-7/7a and VCP/p97 were
cloned into plasmids pDEST-32 and pDEST-22, respectively, and
transformed into the S. cerevisiae reporter strain MaV203 by using
the ProQuest
TM Two-Hybrid System (Invitrogen). Double-trans-
formants were selected on media lacking leucine and tryptophan;
bait-only or prey-only controls were transformed with empty
pDEST-32 or pDEST-22. Interactions were assessed by growth in
the absence of histidine in the presence of 10, 25, 50, or 100 mM
3-aminotriazole histidine synthase antagonist, and by a ˆ-galactosi-
dase assays. For the liquid b-galactosidase assays, cell cultures were
diluted to an O.D.600 of 0.3 in 3 mL media lacking leucine and
tryptophan and grown to a final O.D.600 of 0.8 to 1.5. After
centrifugation, cells were resuspended in 300 mL Z buffer (60 mM
NaH2PO4, 40 mM NaH2PO4, 10 mM KCl, 1 mM MgSO4,
pH 7.0), disrupted by the addition of 150 mg autoclaved acid-
washed glass beads (Sigma G8772), and vortexed for 30 minutes at
4uC. After brief centrifugation, supernatants were brought up to
1 mL total volume in Z buffer containing 25 mM b-mercapto-
ethanol and 2 mM ONPG (dissolved at 4 mg/mL Z buffer
(N1127, Sigma) and incubated at 37uC. Reactions were stopped
by the addition of 1 M Na2CO3, and centrifuged at 14,000 x g.
Supernatants were transferred in triplicate into 96-well plates and
their absorbance was read at 420. Relative b-galactosidase activity
was calculated using the formula (10006Abs)/(t(min)6O.D.600).
The statistical significance of the average activity of each
cotransformant was analyzed using a 1-way analysis of variance
(ANOVA) test of 6 independent experiments.
We thank Drs. Andrea Corse and William Baldwin (Johns
Hopkins University) for providing human tissues for this study,
David Hines (Johns Hopkins University) for technical support, and
Dr. Robbert Creton (Brown University, Providence, RI) for
assistance with the initial zebrafish studies.
Supporting Information
Figure S1 Ponceau S staining of proteins transferred to
nitrocellulose used for the western blot in Figure 5A
shows equal total protein loading (with the exception of
the Day 0 sample).
(PDF)
Figure S2 The sequential expression of UFD2a isoforms
during development in mice is robust across multiple
samples. A second set of mouse tissue lysates were made at
various developmental time points (similar to Figure 6B). Skeletal
muscle (upper panels; pooled gastrocnemius, soleus, and quadri-
ceps muscles) or hearts (lower panels) from E14, E16, and E18
embryos and P1 and P7 pups were dissected from individual
embryos or pups at each time point and analyzed by Western
blotting for UFD2a. Equal total protein loading was assayed by
western blotting for tubulin (bottom panels).
(PDF)
Figure S3 Expression of bait and prey proteins in
transformed MAV203 yeast cells can be detected by
Western Blot. Yeast cells were grown to log phase and
precipitated proteins run on SD-PAGE gels. UFD2a bait proteins
were detected using a polyclonal antibody recognizing the Gal4
DNA binding domain (DB) and the VCP prey protein was
detected using a monoclonal anti-VCP antibody. Rpt5 was used as
a loading control. Note that the anti-Gal4 DB antibody recognized
high molecular weight proteins even in yeast not expressing a
UFD2a bait protein (labeled non-specific).
(PDF)
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